Everyone should keep in mind that "Blue Cross Blue Shield" is just a licensing affiliation. There are 34 independently owned and operated BC/BS affiliated insurance companies that belong to the "association". And each make their own, independent decisions on coverage.
Always up to companies to defend their drugs against patent abuse. Get aggressive now that the Supreme Court looked at Teva being fined $285 million for infringing a GSK use patent. Target generic manufacturers to enforce skinny labels take actions to halt infringement or pull their drug. CV added protection is the primary patent of use of Vascepa. Not a frivolous use patent created to extend patent protection.